![Mingjun Huang](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Provenienza dei contatti di primo grado di Mingjun Huang
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Subsidiary | Pharmaceuticals: Major | 27 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Mingjun Huang tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
Advent International LP
![]() Advent International LP Investment ManagersFinance Advent International LP (Advent) is an independent private equity firm founded in 1984 by Henry H. Haight. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor | |
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
ENZON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
MERCK & CO., INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
NPS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO Director/Board Member | |
Shire ViroPharma, Inc.
![]() Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
OraPharma, Inc.
![]() OraPharma, Inc. Pharmaceuticals: MajorHealth Technology OraPharma, Inc. develops and produces drugs for oral diseases. It offers a suite of products to address a range of patient concerns from the foundation of gums, bone, and teeth to the aesthetics of a whiter smile. The company's products include ARESTIN Microspheres, a locally administered antibiotic indicated as an adjunct to scaling and root planning procedures for the reduction of pocket depth in patients with adult periodontitis; and ONSET Approach, a unique delivery system of locally buffered anesthesia that provides faster onset of anesthesia and a comfortable injection. The company was founded in 1996 and is headquartered in Horsham, PA. | Pharmaceuticals: Major | Founder Chief Executive Officer General Counsel Chief Operating Officer Comptroller/Controller/Auditor | |
EXELIXIS, INC. | Pharmaceuticals: Major | Director/Board Member | |
ESPERION THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Founder | |
MARINUS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman General Counsel | |
Cellzome Ltd.
![]() Cellzome Ltd. Pharmaceuticals: MajorHealth Technology Cellzome Ltd. engages in the research, development, and manufacture of pharmaceutical products. It provides kinase-targeted drugs to treat inflammatory diseases. The company was founded by Gitte Neubauer on December 22, 2003 and is headquartered in Middlesex, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
AEGERION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Founder Director/Board Member | |
University of Pennsylvania | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
ZOETIS INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Hillsdale College | College/University | Undergraduate Degree | |
King's College (Pennsylvania) | College/University | Undergraduate Degree | |
Yale University | College/University | Corporate Officer/Principal Undergraduate Degree Undergraduate Degree | |
The Pennsylvania State University | College/University | Undergraduate Degree Undergraduate Degree | |
St. Joseph's University | College/University | Masters Business Admin Masters Business Admin | |
Lev Pharmaceuticals, Inc.
![]() Lev Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lev Pharmaceuticals, Inc. develops and commercializes therapeutic products for the treatment of inflammatory diseases. It researches a series of drugs to fight both edema and heart attacks. The company was founded on July 21, 2003 and is headquartered in New York, NY. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
National Cancer Institute
![]() National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
Novartis Pharmaceuticals Corp.
![]() Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Sales & Marketing Director/Board Member | |
US Department of Defense (District of Columbia) | Sovereign | Corporate Officer/Principal | |
BLUM GROU | Internet Retail | Corporate Officer/Principal | |
White Cube Management LLC
![]() White Cube Management LLC Miscellaneous Commercial ServicesCommercial Services White Cube Management LLC provides management services. The private company is based in Boston, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Philadelphia College of Osteopathic Medicine | College/University | Corporate Officer/Principal | |
UNIQURE N.V. | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
The Leonard N Stern School of Business | College/University | Masters Business Admin Undergraduate Degree Undergraduate Degree | |
IEcure, Inc.
![]() IEcure, Inc. BiotechnologyHealth Technology iECURE, Inc. is a gene editing company that focuses on developing therapies for liver disorders with significant unmet need. The company is based in Plymouth Meeting, PA, and the CEO of the company is Joseph Truitt. The company's approach involves mutation-agnostic in vivo gene insertion or knock-in editing, which has the potential to replace and restore the function of a dysfunctional gene, regardless of mutation. iECURE collaborates with the University of Pennsylvania's Gene Therapy Program to utilize their translational expertise and infrastructure. The company's management team has extensive experience in executing orphan drug and gene therapy clinical trials and successfully commercializing multiple products. iECURE's programs are currently focused on developing in vivo gene insertion therapies for the treatment of rare pediatric liver diseases. | Biotechnology | Chief Executive Officer Director/Board Member Chief Operating Officer | |
IMMUNOCORE HOLDINGS PLC | Biotechnology | Director of Finance/CFO Investor Relations Contact | |
Avilar Therapeutics, Inc.
![]() Avilar Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Avilar Therapeutics is an American biopharmaceutical company that specializes in the discovery and development of extracellular protein degraders. The company is based in an undisclosed location. The company has developed a proprietary discovery platform that includes novel, high-affinity, small molecule asgpr ligands and advanced modeling of the biophysics, pharmacokinetics, and pharmacodynamics of atac mediated endocytosis and degradation. Avilar is developing atacs, a new class of protein degraders that shuttle disease-causing proteins from circulation to the endolysosome where the unwanted proteins are degraded. The company is leveraging their atac platform to create a broad and diverse pipeline of first-in-class extracellular protein degraders. The company was founded by Nathaniel Brooks Horwitz and Jamie Kasuboski. The CEO is Daniel S. Grau. | Miscellaneous Commercial Services | Chairman Chief Executive Officer | |
RA Capital Management LP (Private Equity)
![]() RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital Management LP (Private Equity) (RA Capital) is a private equity & venture capital subsidiary of RA Capital Management LP founded by Peter Kolchinsky in 2004. The firm is headquartered in Boston, MA. | Investment Managers | Private Equity Investor Consultant / Advisor | |
DiNAQOR AG
![]() DiNAQOR AG BiotechnologyHealth Technology DiNAQOR AG is a Swiss genetic medicine platform company that focuses on developing innovative solutions for patients with severe, inherited forms of heart disease. The private company is based in Pfäffikon, Switzerland, and has additional presence in Massachusetts and other locations. The company's lead preclinical program, DINA-001, is aimed at treating mybpc3-linked cardiomyopathy. Founded in 2019, the CEO of DiNAQOR is Johannes Holzmeister. | Biotechnology | Director/Board Member | |
Code Biotherapeutics, Inc.
![]() Code Biotherapeutics, Inc. BiotechnologyHealth Technology Code Biotherapeutics, Inc. is a next-generation gene therapy company based in Greater Philadelphia. The American company is focused on developing targeted non-viral gene therapies to treat serious and life-threatening genetic diseases. The company uses a novel multivalent synthetic DNA delivery platform called 3DNA, which overcomes many of the challenges associated with viral-based gene therapies. Code Biotherapeutics is advancing an internal pipeline focused on select rare disease programs and establishing partnerships to take forward programs in both rare and prevalent diseases. Code Biotherapeutics is supported by top-tier investors that believe in their work to drive discovery programs forward as they aim to deliver on the promise of their proprietary synthetic DNA-based, non-viral genetic medicines delivery platform. The company was founded by Brian P. McVeigh, who has been the CEO since incorporation. | Biotechnology | Director/Board Member | |
CADRENAL THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Hershey Medical Center | College/University | Corporate Officer/Principal | |
SwanBio Therapeutics, Inc.
![]() SwanBio Therapeutics, Inc. BiotechnologyHealth Technology SwanBio Therapeutics, Inc. operates as a gene therapy firm. The company was founded by Tom Anderson, Rachel Salzman, Karen Kozarsky and Florian S. Eichler and is headquartered in Bala Cynwyd, PA. | Biotechnology | Chief Tech/Sci/R&D Officer |
Statistiche
Distribuzione geografica
Stati Uniti | 46 |
Regno Unito | 3 |
Israele | 2 |
Paesi Bassi | 2 |
Svizzera | 2 |
Settori
Health Technology | 29 |
Consumer Services | 11 |
Finance | 5 |
Commercial Services | 5 |
Technology Services | 2 |
Posizioni
Director/Board Member | 124 |
Corporate Officer/Principal | 58 |
Independent Dir/Board Member | 34 |
President | 25 |
Chairman | 24 |
Contatti più connessi
Insiders | |
---|---|
Jason S. Fisherman | 30 |
Nicole Vitullo | 29 |
Robert van Nostrand | 22 |
David I. Scheer | 19 |
Frank Verwiel | 16 |
Kurt Graves | 15 |
Brian DiDonato | 13 |
Steven Zelenkofske | 13 |
Martha Manning | 13 |
Milind Deshpande | 11 |
Anthony Gibney | 11 |
Douglas John Barry | 10 |
David Apelian | 10 |
Paul Firuta | 10 |
Mary Fenton | 10 |
- Borsa valori
- Insiders
- Mingjun Huang
- Connessioni Società